ClinicalTrials.Veeva

Menu

A Causal Relationship Study Between Anxiety, Depression, and Rheumatoid Arthritis

S

Shate Xiang

Status

Enrolling

Conditions

Depression
Anxiety
Rheumatoid Arthritis

Treatments

Other: No intervention

Study type

Observational

Funder types

Other

Identifiers

NCT05892562
Shate Xiang

Details and patient eligibility

About

Rheumatoid arthritis (RA) is a systemic chronic inflammatory disease, and depression and anxiety are among the most common comorbidities in RA patients, with a high prevalence rate. Epidemiological studies have found that joint deformities, severe pain, positive serum RF titers, as well as comorbidities such as hypertension, insomnia, pain, and fatigue are significantly associated with depression and anxiety in RA patients.

Currently, clinical studies have found that the relief of depression or anxiety is one of the expected treatment goals for RA patients. Due to the unclear pathogenic factors of depression or anxiety in RA patients, there is a lack of effective clinical treatment options. Therefore, this study will use a "causal inference model" to identify possible "mediating variables" that may lead to the comorbidity of RA and emotional disorders through clinical investigation, aiming to improve the precision of treatment for physicians.

Enrollment

500 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with RA.

Exclusion criteria

  • Patients diagnosed as non-RA.

Trial design

500 participants in 2 patient groups

RA combined with depression or anxiety
Treatment:
Other: No intervention
RA without comorbid depression or anxiety
Treatment:
Other: No intervention

Trial contacts and locations

1

Loading...

Central trial contact

Shate Xiang, Master's degree

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems